How often to retest bloodwork: a cadence per marker class

By Marcus Renshaw ·

For most of my first year I retested too early. I would change something, wait three weeks, draw blood, watch the number move in a way I didn’t expect, and change again. Most of what I was reacting to was noise. Every marker has a settling time, and drawing before it settles measures the transient, not the new baseline you actually want to see.

Retest each marker once it reaches a new steady state. In practice that means thyroid (TSH) and testosterone about 6 weeks after a change, lipids at 4 to 12 weeks, and vitamin D, ferritin, and HbA1c at a full quarter. Test sooner only to track a trend or a safety marker, not to read a single number as settled.

Why retesting early wastes the draw

When you change a dose, a supplement, or a habit, the marker it affects does not jump to its new level. It climbs (or falls) along a curve set by its half-life. The rule of thumb from pharmacokinetics is that a value reaches steady state after about five half-lives. Some markers add a second delay on top: a feedback loop that lags, or a cell population that has to turn over.

Draw before that curve flattens and you catch a number mid-move. It reads high or low relative to where it will settle, you treat the transient as the result, and you adjust again. Now two changes are overlapping and neither reading means anything. The whole point of retesting is to compare a settled number to a settled number.

Here is the cadence, then the reasoning per marker.

MarkerRetest after a changeWhy
TSH / thyroid6 to 8 weeksT4 half-life ~7 days, plus pituitary feedback lag
Testosterone~6 weeksLevels settle at the new dose; draw at trough
Lipids4 to 12 weeks (8 optimal)Statins reach full effect in 2 to 4 weeks
Vitamin D (25-OH-D)~12 weeksHalf-life 2 to 3 weeks, slow plateau, fat storage
Ferritin / iron~12 weeksStores refill slowly; Hb moves first
HbA1c3 months minimumRed cells live ~120 days

Thyroid: 6 to 8 weeks after a change

TSH is the classic trap. Levothyroxine (T4) has a half-life of about 7 days, so it needs roughly 5 to 6 half-lives, 35 to 42 days, just to reach a steady blood level. On top of that, the pituitary that produces TSH takes its own time to re-equilibrate to the new thyroid hormone level. That is why the American Thyroid Association and AACE say to recheck TSH 4 to 8 weeks after a dose change, and 6 to 8 weeks is the honest window. Check at two weeks and you will see a number that has not arrived yet. Once you are stable, the interval stretches to every 6 to 12 months.

WARNING

Thyroid and testosterone are prescription-managed. Nothing here is a protocol to run alone. The point is to know when a retest is worth drawing, and to bring settled numbers to whoever manages your treatment.

Testosterone: 6 weeks, and mind the trough

After a change to injectable testosterone, blood levels settle at the new dose over roughly 6 weeks, a timeline set by the ester’s half-life, so a retest before then is premature. The Endocrine Society then monitors on longer intervals, checking testosterone alongside hematocrit and prostate markers across the first year and annually after. Adjust in small increments rather than big jumps, because a big jump plus an early draw is how people end up chasing their own tail.

One detail that matters more than the calendar: if you inject enanthate or cypionate, when in the cycle you draw changes the number. Draw midway between injections for a representative trough-ish reading. Comparing a day-two peak to a day-six trough tells you about your timing, not your dose.

Vitamin D, ferritin, HbA1c: think in quarters

These are the slow markers. Trying to read them monthly is the most common waste of a draw.

Vitamin D (25-OH-D) has a half-life of 2 to 3 weeks, so it takes 8 to 12 weeks to plateau after you change your intake, with a median closer to 16 weeks for a true steady state. It also has a long tail, because vitamin D stored in fat leaks back into serum, so even a one-year value may not be a perfect plateau. Retest at about 12 weeks.

Ferritin refills slowly. After starting oral iron, hemoglobin moves first (a 1 to 2 g/dL rise over 4 to 8 weeks), but ferritin, which reflects stored iron, is best rechecked at about 3 months. And ferritin is an acute-phase reactant: an infection or inflammation flare inflates it, so a “normal” ferritin drawn during a cold can hide a real deficiency.

HbA1c is capped by biology. Red cells live about 120 days, and HbA1c reflects roughly the last 8 to 12 weeks of glucose exposure, weighted toward the most recent 6 weeks. Retesting it sooner than 3 months cannot show you a full new average. The ADA uses 3 months for unstable control and 6 months once stable.

Lipids: 4 to 12 weeks, fasting, after a real change

Statins reach their full lipid-lowering effect within 2 to 4 weeks, so the 2018 AHA/ACC cholesterol guideline says to draw a fasting lipid panel 4 to 12 weeks after starting or changing therapy, with 8 weeks a good default. If the change is diet and exercise rather than a drug, give it a 6 to 12 week trial before you judge it. After that, every 3 to 12 months is plenty.

The guideline cadence is a floor, not a ceiling

Everything above is the clinical answer, and clinics optimize for their own constraints: one managed drug, minimal cost, few false alarms. If you are self-funding and tuning your own protocol toward longevity rather than treating a single deficiency, the calculus changes, and testing more often than the guideline says can be the right call in three cases.

Budget. If you can afford it, an extra draw to catch a trend early instead of confirming it late is often worth the cost. The guideline says do not bother because for a health system the marginal draw is expensive noise. For you it can be cheap signal, as long as you read it as a trend.

A moving prior result. A marker that came back near a threshold or clearly drifting earns a shorter leash than one sitting comfortably mid-range. Fixed intervals are for stable people. Risk-based intervals are for the ones actually optimizing.

Safety markers. Some numbers you watch for danger, not for optimization, and those do not wait for steady state. Hematocrit on testosterone therapy, blood pressure, and hs-CRP: a harmful drift matters long before the value settles, so you keep those on a shorter interval than the pharmacokinetics alone would suggest.

The catch that turns frequent testing into signal instead of the noise I warned about earlier: read the trend across several draws, never a single point. Testing often only helps if you interpret the line, not the dot.

Your stack changes the math

The clinical cadence assumes you changed one thing. Most self-experimenters are running several, and every compound moves a set of markers by an amount that scales with the dose. Testosterone pushes hematocrit and estradiol up and suppresses LH and FSH. A SERM like enclomiphene moves LH, FSH, and estradiol. An oral can nudge lipids and liver enzymes. Run more than one of those at once and their effects land on overlapping markers.

Two things follow. First, attribution: if two compounds both push hematocrit and you change both, a single retest tells you the number moved and nothing about which lever did it. You either move one variable at a time or you accept you are reading the net effect, not a clean signal. Second, cadence: the more compounds stacking on one marker, and the higher the doses, the more a tight watch earns its cost, especially on the safety markers above.

So the honest version of “how often” is not a fixed table. It is: set the interval from the marker’s biology as a floor, then tighten it for your budget, your risk, and your stack. Keep a map of which of your compounds move which markers, at what dose, so a draw is read against your actual inputs instead of a textbook average. Most of my own useless draws were the ones where I had changed two things at once: adjust an enclomiphene dose and start something new in the same month, and the result tells you a number moved and nothing about which move did it. Now I change one variable at a time when I can, and when I cannot, I read the number as the net, not a clean signal.

Some compounds do not just move a marker, they distort it. On a 5-alpha-reductase inhibitor like dutasteride, common for hair, your PSA reads about half its true value, so you double it in your head and tell any doctor interpreting it that you are on the drug. I learned that one the mildly alarming way. A result is only meaningful read against what you are actually taking.

This is the real job of the supplement and compound journal beside the bloodwork tracker in the bundle I built: your stack and doses logged next to the markers they move, so every retest reads against what you are actually taking, not a guideline written for someone on one prescription. And read each settled number against the right target, because reference ranges and optimal ranges are not the same thing.

Pick one marker you changed recently. Set its floor interval from the table, then ask whether your budget, a moving prior result, or your stack argues for tighter. Put that date in the calendar, and read the trend, not the dot.

FAQ

How soon can I retest thyroid after a dose change?

Wait 6 to 8 weeks. Levothyroxine’s ~7-day half-life needs 5 to 6 half-lives to reach a steady blood level, and the pituitary adds more feedback lag. The ATA and AACE recommend rechecking TSH 4 to 8 weeks after a change. Earlier readings show a level that has not arrived yet.

Why does vitamin D take so long to retest?

25-OH-D has a half-life of 2 to 3 weeks, so it plateaus over 8 to 12 weeks after you change your intake, and vitamin D stored in body fat keeps leaking back into the blood, stretching the tail out further. Retest at about 12 weeks, not monthly.

Can I retest everything at the same time?

You can draw everything at once, but the results are only meaningful for the markers whose settling time has passed since your last change. If you changed your thyroid dose two weeks ago, that TSH is noise even if the rest of the panel is fine. Anchor each marker to its own change and interval.

Why retest HbA1c only every 3 months?

Because red cells live about 120 days and HbA1c is an average of roughly the last 8 to 12 weeks of glucose. A retest sooner than 3 months physically cannot reflect a full new average, so it mostly measures the change you already knew about.

When should I draw testosterone if I inject weekly?

Draw midway between injections for a representative trough-side reading, and keep the timing identical each time. A peak-day draw compared to a trough-day draw tells you about your injection timing, not your dose.

Does retesting too often actually hurt anything?

It costs money and, worse, it manufactures false signals. An early draw catches a marker mid-move, you treat the transient as real, you adjust again, and now overlapping changes make every future reading harder to interpret. Patience is the cheaper tool.

How do I know a change actually worked?

Compare two settled numbers: a baseline before the change, and a retest after the marker’s full equilibration time has passed, with nothing else changed in between. If you altered three things at once, you learned nothing about any of them.

Should I test more often than the guidelines say?

If you can afford it and you read results as trends rather than single points, yes. Guideline intervals are floors set for cost-conscious clinics managing one drug. Tighten them when a prior result was moving, when a marker is a safety marker like hematocrit or blood pressure, or when your stack makes a marker worth watching. Read the line across draws, not one dot.

How does my compound stack affect when to retest?

Every compound moves specific markers, and the dose scales the effect. If several compounds hit the same marker and you change more than one, a single retest cannot tell you which did what, so you change one variable at a time or accept you are reading the net. More compounds and higher doses on a marker, especially a safety marker, argue for a tighter interval than the textbook.

Sources